findmyKOL

Jose Cabassa, MD

Basic profile

Mount Sinai Beth Israel

ORCIDNone on fileNPI
RegionNew York, NY · NortheastSpecialtyNeurologyFocusNeurology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2016Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Jose Cabassa is a Neurology physician affiliated with Mount Sinai Beth Israel. OpenAlex indexes 10 publications with 711 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
10publications

Distinct works indexed by OpenAlex.

711citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
37companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

205 E 111th St
New York, NY 100292901

Telephone

646-864-0213

Registry record last updated 17 Mar 2018.

View the NPPES registry record

Industry payments

37 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    71.6%
    Gabapentinoids24.7%
    Gabapentin99%Pregabalin1%
    Part D<11 patients
    Aromatic Amino Acid Decarboxylation Inhibitor14.3%
    Carbidopa-Levodopa86%Rytary14%
    Part D108 patients

    + 17 more classes in this area

  • Musculoskeletal

    24.4%
    gamma-Aminobutyric Acid-ergic Agonist15.6%
    Baclofen100%
    Part D165 patients
    Neuromuscular Blocker4.5%
    Botox77%Dysport23%
    Part D64 patients

    + 2 more classes in this area

  • Cardiovascular

    3.1%
    Angiotensin receptor blocker (ARB)1%
    Losartan Potassium76%Valsartan25%
    Part D<11 patients
    Calcium channel blocker0.8%
    Amlodipine Besylate100%
    Part D11 patients

    + 3 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”